Influence of right ventricular function on the development of primary graft dysfunction after Lung transplantation

被引:7
|
作者
Perez-Teran, Purificacion [1 ,2 ]
Roca, Oriol [1 ,3 ]
Rodriguez-Palomares, Jose [4 ]
Sacanell, Judit [1 ]
Leal, Sandra [1 ]
Sole, Joan [5 ]
Rochera, Maria I. [6 ]
Roman, Antonio [7 ]
Ruiz-Rodriguez, Juan C. [1 ]
Gea, Joaquim [3 ,8 ,9 ]
Evangelista, Arturo [4 ]
Masclans, Joan R. [3 ,9 ,10 ]
机构
[1] Vall Hebron Univ Hosp, Crit Care Dept, Inst Recerca Vall Hebron VHIR, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
[3] Inst Salud Carlos III, CibeRes Ciber Enfermedades Respiratorias, Madrid, Spain
[4] Vall Hebron Univ Hosp, Dept Cardiol, Barcelona, Spain
[5] Vall Hebron Univ Hosp, Dept Thorac Surg, Barcelona, Spain
[6] Vall Hebron Univ Hosp, Dept Anesthesiol, Barcelona, Spain
[7] Vall Hebron Univ Hosp, Resp Dept, Barcelona, Spain
[8] Univ Pompeu Fabra, Barcelona, Spain
[9] Hosp Mar Parc Salut Mar Barcelona, Inst Hosp Mar Investigac Med IMIM, Resp Dept, Barcelona, Spain
[10] Hosp Mar Parc Salut Mar Barcelona, Inst Hosp Mar Investigac Med IMIM, Crit Care Dept, Barcelona, Spain
关键词
primary graft dysfunction; lung transplant; right ventricle; speckle-tracking echocardiography; ISHLT WORKING GROUP; SPECKLE-TRACKING STRAIN; CLINICAL RISK-FACTORS; PULMONARY-HYPERTENSION; INTERNATIONAL-SOCIETY; EUROPEAN-ASSOCIATION; SYSTOLIC FUNCTION; AMERICAN-SOCIETY; ECHOCARDIOGRAPHY; HEART;
D O I
10.1016/j.healun.2015.05.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Primary graft dysfunction (PGD) remains a significant cause of lung transplant postoperative morbidity and mortality. The underlying mechanisms of PGD development are not completely understood. This study analyzed the effect of right ventricular function (RVF) on PGD development. METHODS: A retrospective analysis of a prospectively assessed cohort was performed at a single institution between July 2010 and June 2013.. The primary outcome was development of PGD grade 3 (PGD3). Conventional echocardiographic parameters and speckle-tracking echocardiography, performed during the pre-transplant evaluation phase up to I year before surgery, were used to assess preoperative RVF. RESULTS: Included were 120 lung transplant recipients (LTr). Systolic pulmonary arterial pressure (48 +/- 20 vs 41 +/- 18 mm Hg; p = 0.048) and ischemia time (349 +/- 73 vs 306 +/- 92 minutes; p < 0.01) were higher in LTr who developed PGD3. Patients who developed PGD3 had better RVF estimated by basal free wall longitudinal strain.(BLS; -24% 9% vs -20% +/- 6%; p = 0.039) but had a longer intensive care unit length of stay and mechanical ventilation and higher 6-month mortality. BLS >= -21.5% was the cutoff that best identified patients developing PGD3 (area under the receiver operating characteristic curve, 0.70; 95% confidence interval, 0.54-0.85; p = 0.020). In the multivariate analysis, a BLS >= -21.5% was an independent risk factor for PGD3 development (odds ratio, 4.56; 95% confidence interval, 1.20-17.38; p = 0.026), even after adjusting for potential confounding. CONCLUSIONS: A better RVF, as measured by BLS, is a risk factor for severe POD. Careful preoperative RVF assessment using speckle-tracking echocardiography may identify LTrs with the highest risk of developing PGD. (C) 2015 International Society for Heart and Lung Transplantation. All rights reserved.
引用
收藏
页码:1423 / 1429
页数:7
相关论文
共 50 条
  • [31] Intraoperative Red Blood Cell Transfusion and Primary Graft Dysfunction After Lung Transplantation
    Subramaniam, Kathirvel
    Loor, Gabriel
    Chan, Ernest G.
    Bottiger, Brandi A.
    Ius, Fabio
    Hartwig, Matthew G.
    Daoud, Daoud
    Zhang, Qianzi
    Wei, Qi
    Villavicencio-Theoduloz, Mauricio A.
    Osho, Asishana A.
    Chandrashekaran, Satish
    Noguchi Machuca, Tiago
    Van Raemdonck, Dirk
    Neyrinck, Arne
    Toyoda, Yoshiya
    Kashem, Mohammed A.
    Huddleston, Stephen
    Ryssel, Naomi R.
    Sanchez, Pablo G.
    TRANSPLANTATION, 2023, 107 (07) : 1573 - 1579
  • [32] Volatile organic compound profiling to explore primary graft dysfunction after lung transplantation
    Stefanuto, Pierre-Hugues
    Romano, Rosalba
    Rees, Christiaan A.
    Nasir, Mavra
    Thakuria, Louit
    Simon, Andre
    Reed, Anna K.
    Marczin, Nandor
    Hill, Jane E.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [33] Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation
    Jenkins, J. Asher
    Verdiner, Ricardo
    Omar, Ashraf
    Farina, Juan Maria
    Wilson, Renita
    D'Cunha, Jonathan
    Dos Santos, Pedro Augusto Reck
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [34] A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome
    Van Slambrouck, Jan
    Van Raemdonck, Dirk
    Vos, Robin
    Vanluyten, Cedric
    Vanstapel, Arno
    Prisciandaro, Elena
    Willems, Lynn
    Orlitova, Michaela
    Kaes, Janne
    Jin, Xin
    Jansen, Yanina
    Verleden, Geert M.
    Neyrinck, Arne P.
    Vanaudenaerde, Bart M.
    Ceulemans, Laurens J.
    CELLS, 2022, 11 (04)
  • [35] Recipient, donor, and surgical factors leading to primary graft dysfunction after lung transplant
    Toyoda, Takahide
    Cerier, Emily Jeong
    Manerikar, Adwaiy Jayant
    Kandula, Viswajit
    Bharat, Ankit
    Kurihara, Chitaru
    JOURNAL OF THORACIC DISEASE, 2023, 15 (02) : 399 - +
  • [36] Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction
    Wong, Wai
    Johnson, Brandy
    Cheng, Pi Chun
    Josephson, Maureen B.
    Maeda, Katsuhide
    Berg, Robert A.
    Kawut, Steven M.
    Harhay, Michael O.
    Goldfarb, Samuel B.
    Yehya, Nadir
    Himebauch, Adam S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (05) : 669 - 678
  • [37] Construct validity of the definition of primary graft dysfunction after lung transplantation
    Christie, Jason D.
    Bellamy, Scarlett
    Ware, Lorraine B.
    Lederer, David
    Hadjiliadis, Denis
    Lee, James
    Robinson, Nancy
    Localio, A. Russell
    Wille, Keith
    Lama, Vibha
    Palmer, Scott
    Orens, Jonathan
    Weinacker, Ann
    Crespo, Maria
    Demissie, Ejigaehu
    Kimmel, Stephen E.
    Kawut, Steven M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (11) : 1231 - 1239
  • [38] A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation
    Shah, Rupal J.
    Bellamy, Scarlett L.
    Localio, A. Russell
    Wickersham, Nancy
    Diamond, Joshua M.
    Weinacker, Ann
    Lama, Vibha N.
    Bhorade, Sangeeta
    Belperio, John A.
    Crespo, Maria
    Demissie, Ejigayehu
    Kawut, Steven M.
    Wille, Keith M.
    Lederer, David J.
    Lee, James C.
    Palmer, Scott M.
    Orens, Jonathan
    Reynolds, John
    Shah, Ashish
    Wilkes, David S.
    Ware, Lorraine B.
    Christie, Jason D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (09) : 942 - 949
  • [39] Mitigation of Primary Graft Dysfunction in Lung Transplantation: Current Understanding and Hopes for the Future
    Wilkey, Barbara J.
    Abrams, Benjamin A.
    SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 24 (01) : 54 - 66
  • [40] C1-Esterase-Inhibitor for Primary Graft Dysfunction in Lung Transplantation
    Sommer, Wiebke
    Tudorache, Igor
    Kuehn, Christian
    Avsar, Murat
    Salman, Jawad
    Ius, Fabio
    Gras, Clemens
    Weber, Petra
    Welte, Tobias
    Gottlieb, Jens
    Haverich, Axel
    Warnecke, Gregor
    TRANSPLANTATION, 2014, 97 (11) : 1185 - 1191